BIOMAT Database Logo BIOMAT Database Logo

Cerebrotendinous xanthomatosis: a treatable hereditary neuro-metabolic disease. 2010

Ana Claudia Rodrigues de Cerqueira, and Antônio Egídio Nardi, and Jose Marcelo Ferreira Bezerra

UI MeSH Term Description Entries
D008297 Male Males
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D019294 Xanthomatosis, Cerebrotendinous An autosomal recessive lipid storage disorder due to mutation of the gene CYP27A1 encoding a CHOLESTANETRIOL 26-MONOOXYGENASE. It is characterized by large deposits of CHOLESTEROL and CHOLESTANOL in various tissues resulting in xanthomatous swelling of tendons, early CATARACT, and progressive neurological symptoms. Van Bogaert-Scherer-Epstein Disease,Cerebral Cholesterinosis,Cerebrotendinous Xanthomatosis,Bogaert-Scherer-Epstein Disease, Van,Cerebral Cholesterinoses,Cerebrotendinous Xanthomatoses,Disease, Van Bogaert-Scherer-Epstein,Van Bogaert Scherer Epstein Disease,Xanthomatoses, Cerebrotendinous
D019826 Cholic Acid A major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholbam

Related Publications

Ana Claudia Rodrigues de Cerqueira, and Antônio Egídio Nardi, and Jose Marcelo Ferreira Bezerra
[Cerebrotendinous xanthomatosis--a treatable metabolic disorder].
June 2004, Der Nervenarzt,
Ana Claudia Rodrigues de Cerqueira, and Antônio Egídio Nardi, and Jose Marcelo Ferreira Bezerra
[Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
December 2002, Der Nervenarzt,
Ana Claudia Rodrigues de Cerqueira, and Antônio Egídio Nardi, and Jose Marcelo Ferreira Bezerra
Cerebrotendinous xanthomatosis: a treatable neurodegenerative disease.
October 2009, The Journal of the Association of Physicians of India,
Ana Claudia Rodrigues de Cerqueira, and Antônio Egídio Nardi, and Jose Marcelo Ferreira Bezerra
Cerebrotendinous xanthomatosis: a treatable cause of metabolic ataxia.
September 2007, The Journal of the Association of Physicians of India,
Ana Claudia Rodrigues de Cerqueira, and Antônio Egídio Nardi, and Jose Marcelo Ferreira Bezerra
Cerebrotendinous xanthomatosis: a treatable ataxia.
April 2005, Neurology,
Ana Claudia Rodrigues de Cerqueira, and Antônio Egídio Nardi, and Jose Marcelo Ferreira Bezerra
Cerebrotendinous xanthomatosis is treatable.
July 1985, Pediatric dermatology,
Ana Claudia Rodrigues de Cerqueira, and Antônio Egídio Nardi, and Jose Marcelo Ferreira Bezerra
[Cerebrotendinous xanthomatosis, a rare, severe, but treatable metabolic disorder].
April 2013, Revue medicale de Liege,
Ana Claudia Rodrigues de Cerqueira, and Antônio Egídio Nardi, and Jose Marcelo Ferreira Bezerra
Cerebrotendinous xanthomatosis (CTX): a treatable lipid storage disease.
September 2009, Pediatric endocrinology reviews : PER,
Ana Claudia Rodrigues de Cerqueira, and Antônio Egídio Nardi, and Jose Marcelo Ferreira Bezerra
[Treatable hereditary neuro-metabolic diseases].
October 2007, Revue neurologique,
Ana Claudia Rodrigues de Cerqueira, and Antônio Egídio Nardi, and Jose Marcelo Ferreira Bezerra
Cerebrotendinous Xanthomatosis: A Treatable Genetic Disease Not to Be Missed.
March 2016, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
Copied contents to your clipboard!